Survey respondents who were aware of GLP - 1 drugs yet were not using them cited reasons such as the high cost (treatments currently cost over $1,000 per month), limited insurance coverage, required weekly injections for sustained results and concerns about side effects such as nausea
The following evidence-based strategies align with NHS and NICE Clinical Knowledge Summaries (CKS) guidance
H-440.842 Recognition of obesity as a disease
Pottegrd A, Schmidt SAJ, Wallach-Kildemoes H, Srensen HT, Hallas J, Schmidt M (2017) Data resource profile: the Danish national prescription registry
This becomes especially important during early treatment stages, when appetite and dietary habits may change.Read our guide on hydration while using Wegovy for more practical tips on maintaining optimal fluid levels during treatment